Tsinghua’s Venture Arm Leads $18M Round In Cancer Diagnosis Start-Up
February 10, 2017 — 09:22 CST
This Data Is Locked!
This area is available only to Subscribers.
Beijing-based THG Ventures, a venture capital arm of Tsinghua Holdings, has led a RMB128 million (US$18 million) series B round in Genecast, a Beijing-based cancer... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals